Yahoo Web Search

  1. Ads
    related to MERCK & CO., INC
  1. Merck & Co., Inc. MRK announced that the FDA has accepted its new drug application (NDA) and a supplemental NDA (sNDA) for its antibacterial medicine Dificid (fidaxomicin ...

  2. Merck Sees Hammer Chart Pattern: Time to Buy?

    Zacks via Yahoo FinanceOct 02 8:19 AM

    Merck & Co., Inc. MRK has been struggling lately, but the selling pressure may be coming to an end soon. What is a Hammer Chart Pattern? A hammer chart pattern is a popular ...

  3. Here is Hedge Funds’ 30th Most Popular Stock Pick

    Insider Monkey via Yahoo FinanceOct 04 15:03 PM

    Merck & Co., Inc. (NYSE:MRK) investors should be aware of an increase in support from the world's most elite money managers of late. MRK was in 70 hedge funds' portfolios ...

  4. Kenneth Frazier, the CEO of pharmaceutical giant Merck (MRK), said on Thursday he decided to publicly resign from one of President Trump's councils in the summer of 2017 because he felt ...

  5. Merck (MRK) Stock Moves -0.68%: What You Should Know

    Zacks via Yahoo FinanceOct 01 21:45 PM

    Merck (MRK) closed the most recent trading day at $83.61, moving -0.68% from the previous trading session. Coming into today, shares of the pharmaceutical company had lost 2.65% in the ...

  6. What's Behind PDS Biotech's Rally?

    Benzinga via Yahoo FinanceOct 03 15:45 PM

    PDS, which engages in the development of multifunctional immunotherapic products, announced a modified clinical trial collaboration agreement with Merck & Co., Inc. NYSE ...

  7. Stocks recently featured in the blog include: General Dynamics GD, Merck & Co. MRK, Progressive PGR, ServiceNow NOW and Emerson EMR. The Zacks Research Daily presents the best ...

  8. Hedge Funds Sticking With Coca-Cola Company (KO) Were Rewarded

    Insider Monkey via Yahoo FinanceOct 07 15:29 PM

    Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 10 percentage points over the last 12 months. SEC ...

  9. Seattle Genetics (SGEN) and Astellas' enfortumab vedotin in combination with Merck's Keytruda proves safety in a phase I study as a first-line treatment for advanced bladder cancer. Shares up.

  10. Top Ranked Growth Stocks to Buy for October 10th

    Zacks via Yahoo FinanceOct 10 14:23 PM

    Quote Meritage Homes Corporation (MTH):This home construction company, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% ...

  1. Ads
    related to MERCK & CO., INC